Manager, Analytical Development
Indivior
About this role
The Manager, Analytical Development leads analytical method design, development, and validation to support drug product development and lifecycle management. The role ensures analytical strategies meet regulatory standards and product quality requirements across clinical and commercial stages. Based in Raleigh, NC, the position reports to the Director of Drug Product Development at Indivior.
Skills
Qualifications
About Indivior
indivior.comIndivior is working to change patients lives by developing medicines to treat addiction and serious mental illnesses.
Recent company news
National TodayIndivior Prices $450 Million Convertible Senior Notes Offering
15 hours ago
BitgetINDIVIOR PLC disclosed today that the company plans to publicly offer convertible senior notes due 2031 with a total amount of $400 million.
1 day ago
Investing.comIndivior director Kingsley buys $29,953 in shares
2 days ago
GuruFocusIndivior (INDV) Plans $400 Million Convertible Notes Offering
1 day ago
MarketBeatVictory Capital Management Inc. Makes New $19.44 Million Investment in Indivior PLC $INDV
2 days ago
About Indivior
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for Indivior.
Salary
$140k – $183k
per year
More jobs at Indivior
Similar Jobs
Director, Analytical Development
AbbVie
Associate Director, Analytical Development
Olema Oncology
Director, Analytical Development and Quality Control
Relay Therapeutics
Associate Director, Analytical Development
Olema Oncology
Senior Director, Analytical Development, CMC Small Molecule
Centessa Pharmaceuticals, LLC
Associate Director-Analytical Method Validation & Transfer
glenmarkpharma